Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 429 | 5,200 | 0 | 0 | 0 |
| Gross Profit | 429 | 5,200 | N/A | N/A | N/A |
| Operating Expenses | 30,528 | 33,468 | 0 | 0 | 0 |
| Operating Income | -30,099 | -28,268 | N/A | N/A | N/A |
| Interest Expense | 1,389 | 1,630 | 0 | 0 | 0 |
| Other Income | -4,365 | 43 | 0 | 0 | 0 |
| Pre-tax Income | -35,853 | -29,855 | 0 | 0 | 0 |
| Net Income Continuous | -35,853 | -29,855 | N/A | N/A | N/A |
| Minority Interests | N/A | -61 | N/A | N/A | N/A |
| Net Income | $-35,853 | $-29,794 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -159.50 | -26.50 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -212.70 | -27.34 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -159.50 | -26.50 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -212.70 | -27.34 | N/A | N/A | N/A |
| EBITDA(a) | $-29,091 | $-27,408 | $N/A | $N/A | $N/A |